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Cell Proliferation and Renal Carcinogenesis
by Brian G. Short
Enhanced cell proliferation occurs at several stages of renal tumorigenesis. Initiation by
genotoxic nephrocarcinogens such as dimethylnitrosamine (DMN) is likely a result of DNA
damage coupled with an initial burst of DNA synthesis associated with the cytotoxic effects of
the compound. The level ofinitiation by DMN can be further enhanced by unilateral nephrecto-
my or hydronephrosis, which induces a briefburst ofcell proliferation followed by tumorigene-
sis in the contralateral kidney. The role of sustained cell proliferation in renal tumor develop-
ment is less well understood. The most compelling evidence comes from studies with
nongenotoxic renal carcinogens such as unleaded gasoline and d-limonene, which induce a2U-
globulin (aG) nephropathy and renal epithelial tumors exclusively in male rats. Sustained
increases in cell proliferation in these studies depend on the presence of a chemical-aG com-
plex in phagolysosomes of P2 proximal tubule cells, which results in cytotoxicity and compen-
satory hyperplasia only in male F344 rats, but not female F344 rats or aG deficient male NBR
rats. Furthermore, initiation-promotion experiments demonstrated a strong correlation between
the dose-response of cell proliferation and the incidence of preneoplastic and neoplastic
lesions. Clearly, similar correlative studies with a number of other renal carcinogens and non-
carcinogens are warranted before general conclusions can be made. Cell proliferation is exces-
sively elevated in tubules affected by chronic progressive nephropathy, but the significance of
the lesion to renal carcinogenesis is unclear. Elucidating mechanisms ofrenal cell proliferation
are necessary for our understanding of cause and effect relationships. An exciting recent find-
ing is altered expression oftransforming growth factor-a in hereditary rat renal cell carcinoma.
This animal model may be useful for studying detailed histochemical relationships between
altered growth factors and cell proliferation in various stages ofrenal carcinogenesis.
Introduction
Limited knowledge exists for evaluating the role of
renal cell proliferation in renal carcinogenesis. Com-
pounds from diverse chemical classes that induce renal
tumors in different species of experimental animals
have been reviewed (1,2) The broad morphological
array oftumor types (e.g., nephroblastoma, renal mes-
enchymal tumors, renal epithelial tumors, and renal
transitional tumors) reflect the marked heterogeneity
of cell types ofthe kidney. Renal epithelial cell tumors
comprises the vast majority of induced tumors, often
with specific sites oforigin within various segments of
proximal and distal tubules and collecting ducts. For
these reasons, evaluation ofcell proliferation should be
conducted within specific subpopulations of the
nephron. Information on toxicokinetics, metabolism,
genotoxicity, cytotoxicity, repair, and gene expression
Department of Toxicology-U.S., SmithKline Beecham Pharma-
ceuticals, UE0364, King ofPrussia, PA 19406.
This paper was presented at the Symposium on Cell Proliferation
and Chemical Carcinogenesis that was held January 14-16, 1992, in
Research Triangle Park, NC.
induced by a particular chemical may also be necessary
to properly assess the relationship between cell prolifer-
ation and renal cancer.
Renal Cell Proliferation in Initiation
Cell proliferation is required for the conversion of
DNA lesions to mutations. Sustained elevations in cell
proliferation may also yield mutations secondary to
errors in DNA synthesis and/or endogenous DNA
damage. Thus, an agent can increase the probability of
DNA damage by either directly altering the DNA or
by increasing the number of times DNA replicates. In
the kidney, the evidence for cell proliferation enhanc-
ingthe rate ofinitiation has been evaluated in a limited
number of experimental studies. In the case of mes-
enchymal and cortical epithelial renal neoplasms
induced by dimethylnitrosamine (DMN), a correlation
exists between the ability of this renal carcinogen to
cause toxic injury and to stimulate apulse ofearly pro-
liferation in the same cell populations that give rise to
tumors (3). Thus, the DNA damage induced by DMN
in the resident cortical fibrocyte and proximal tubule
epithelial cells is fixed by the proliferative stimulus of
DMN.B. G. SHORT
The level of initiation by DMN can be further
enhanced by unilateral nephrectomy or hydronephro-
sis, which induces a briefburst of cell proliferation fol-
lowed by tumorigenesis in the contralateral kidney (4).
These experiments are similar in principle to those in
the liver, in which hepatocyte initiation is enhanced by
partial hepatectomy. However, mechanistic studies in
the liver, which demonstrated that initiation is highest
when DNA injury has been induced immediately pre-
ceding the S phase of DNA synthesis (5), have not
been conducted in the kidney. Studies in the liver have
demonstrated that proliferation induced by mitogenic,
as opposed to cytotoxic, agents does not enhance hepa-
tocyte initiation (6,7). These investigators have sug-
gested that initiated cells formed after exposure to
mitogenic agents are prone to apoptosis, which elimi-
nates initiated cells. Similar mitogenic agents for the
kidney, such as lead nitrate, induce apoptosis after
withdrawal ofthe mitogenic stimulus, (8) but the effect
ofmitogenic agents on renal initiation is unknown.
Induced cell proliferation may yield mutations direct-
ly by fixing endogenous DNA damage. This hypothesis
has no direct experimental evidence in the kidney, but
the idea deserves support because it may explain how
nongenotoxic carcinogens increase the number ofspon-
taneously initiated cells and thus contribute to the car-
cinogenicity ofthese agents.
Renal Cell Proliferation in
Promotion and Progression
Increased rates of cell proliferation may be impor-
tant in the promotion and progression phases of car-
cinogenesis by increasing the clonal expansion of initi-
ated cells (9). Cell proliferation is essential for tumor
formation, as cancer is aproliferative disease by defini-
tion (10). Correlations between increased cell prolifera-
tion and tumor development in the target organ are
usually based on incomplete data because proliferation
rates are collected at a single, early time point. Studies
of renal cell proliferation at multiple time points are
lacking. Furthermore, most studies have not identified
the target renal cell population for tumorigenesis.
Therefore, relatively few examples exist that ade-
quately support the correlation between renal cell pro-
liferation and tumorpromotion.
a2u-Globulin Inducing Agents
Many chemicals have been identified that induce a2,-
globulin (aG) nephropathy and renal cancer exclusive-
ly in male F344 rats (Table 1), and these chemicals
have been reviewed elsewhere (11,12). Increases in
renal cell proliferation associated with aG nephropa-
thy have been demonstrated in male rats after acute
exposure to pentachloroethane and perchloroethylene
(14) and 1,4-dichlorobenzene (23,28). Sustained increas-
es in cell proliferation associated with aG nephropathy
have been demonstrated in male rats after acute or
Table 1. Chemicals reported to cause male rat-specific
a2.-globulin nephropathy and renal carcinogenesis.
Chemical References
Pentachloroethane (13,14)
Unleaded gasoline (15,16)
JP-5jet fuel (17,18)
Isophorone (19,20)
Perchloroethylene (14,21)
1,4-Dichlorobenzene (22,23)
Dimethylmethylphosphonate (24)
Hexachloroethane (25)
d-Limonene (26,27)
chronic exposure to unleaded gasoline [UG (29,30)] or
d-limonene [dL(31)]. Five- to 11-fold increases in P2
cell proliferation observed after 6 or 12 months of
exposure to UG or dL were strongly correlated with
the presence of chemical-aG complex in phagolyso-
somes of P2 proximal tubule cells of male rats.
Furthermore, the absence of aG nephropathy and P2
cell proliferation in female F344 rats exposed to UG or
in aG-deficient male NBR rats exposed to dL demon-
strated the requirement of this protein for protein
droplet nephropathy and cell proliferation. In addition,
initiation-promotion experiments ofUG and dL demon-
strated a strong correlation between the presence of
increased cell proliferation and promotion of preneo-
plastic and neoplastic lesions (31,32). These experi-
ments with UG and dL provide a convincing case for a
causal relationship between cell proliferation and renal
carcinogenesis in male rats.
Cell proliferation is increased in P3 cells and proxi-
mal tubular cells within foci of chronic progressive
nephrosis (CPN) from rats exposed to UG (30).
Although the mechanism for increased cell prolifera-
tion of P3 and CPN tubules is unknown, the cause is
most likely secondary to cytotoxicity observed in P2
segments. In any event, these cells types may also be
at risk fordevelopingrenal tumors.
The magnitude and duration ofincreases in renal cell
labeling index necessary for kidney tumor formation
are unknown, but these few examples with a-inducing
agents suggest that P2 cell labeling indexes of5-fold or
greater for at least 6 months are needed. Twenty-one-
month recovery studies after 3 months of exposure to
decaline or JP-8 were not associated with a tumor
response, suggesting that a longer exposure period
may be required for tumor formation (17,33). Per-
chloroethylene causes aG nephropathy at high gavage
or inhalation concentrations, but a 28-day inhalation
exposure study of male rats to 400 ppm, a concentra-
tion associated with kidney tumors, did not cause aG
nephropathy in these rats (14,34). Recently, the phar-
maceutical agent, 1-(aminomethyl)cyclohexaneacetic
acid, was shown to induce aG nephropathy but not
renal tumors in a2-yearbioassay in rats (35). Male rats
exposed to this chemical may have had insufficient
renal tubular injury and regeneration to effectively
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promote tumor formation. Clearly, data on magnitude
and duration of cell proliferation following chronic
exposure to these and other aG-inducing agents are
required to enhance our understanding ofthe relation-
ships between aG nephropathy, cell proliferation, and
renal cancer in male rats. Although increased cell pro-
liferation appears to be a necessary event for the for-
mation of renal tumors caused by aG-inducing agents,
other contributing mechanisms may also be present in
some cases. Forexample, genotoxicity ofperchloroethy-
lene through the glutathione conjugation/4-lyase path-
way in the rat may contribute to the development of
kidney tumors caused by this aG-inducing agent (34).
Sodium Barbital
Sodium barbital (NaBB), a renal tumor promoter
and weak renal carcinogen, induced chronic nephropa-
thy resembling CPN and sustained, 5- to 10-fold
increases in renal cell proliferation over a 2- to 52-
week exposure period (36). Cell proliferation studies of
the renal tumor-promoting activity of NaBB after ini-
tiation with streptozotocin (STZ) demonstrated ame-
lioration of the NaBB-induced nephropathy and a
decreased proliferative response after STZ treatment
(37). However, STZ initiation did not abolish the renal
tumor-promoting effect of this compound, implying a
lack ofcorrelation between cell proliferation and renal-
promoting effect. The authors acknowledged that spe-
cific cell types were not counted separately and that
the proliferative rate of renal cells seemed to be a
more accurate quantitative index of the severity of
nephropathy. The authors suggested that tumor pro-
moters may target initiated cells for mitogenesis
rather than noninitiated parenchymal cells, which
undergo hyperplasia as a reparative response to cyto-
toxicity. These initiated cells may have different
growth control mechanisms than noninitiated cells and
their response to mitogens or toxins may differ as for
hepatocytes. Studies such as this indicate the impor-
tance of attempting to identify initiated (target) cells
within the renal tubule that respond to the mitogenic
or other effects of tumor promoters. It is suggested
that quantification of labeled cells within areas resem-
bling CPN should be separated from more normal-
appearing renal cells because the contribution of CPN
tubules to renal cancer is yet to be defined.
Miscellaneous Chemicals,
Hormones, and Drugs
Lead acetate, a renal carcinogen and tumor promot-
er in rats, induces sustained, 15-fold increases in cell
proliferation in proximal tubule cells (38-40). Estrogen-
induced kidney tumors in hamsters may be caused by
both mitogenic effects and formation ofreactive estro-
gen metabolites (41). Characterization of early kidney
lesions in diethylstilbestrol-induced tumors in ham-
sters implicate the primitive interstitial cell, which dif-
ferentiates into malignant tubules (42). Cell prolifera-
tion studies ofestrogenic compounds may also be com-
plicated by the fact that different cell types are affect-
ed by various estrogenic compounds, such as
diethylstilbestrol, and ethinyl estradiol.
Sustained cytotoxicity, preneoplastic lesions, and
renal cell tumors are observed with a number of
agents, including antibiotics, analgesics, metal com-
pounds, mycotoxins, tumor promoters, and other
agents (1,2,43,44). Although it is reasonable to suggest
that cell proliferation may be associated with the
tumorigenic effects of these agents, the data are lack-
ing. Renal toxicity and hyperplasia has also been
observed without a carcinogenic effect following chron-
ic exposure to several chemicals, including chloro-
methane, hydrochlorothiazide, a-methyldopa, toluene,
and mercuric chloride (44,45). Cell proliferation studies
ofrenal carcinogens as well as noncarcinogens are war-
ranted to clarify the role ofsustained proliferation and
renal tumorigenesis.
Developing a Data Set on
Cytotoxicity, Cell Proliferation, and
Renal Cell Tumors
Several key ingredients of cell proliferation studies
are necessary to establish relationships of cytotoxicity
to renal tumors (Table 2). Examination ofcell prolifer-
ation at bioassay doses and at multiple time points is
critical. Cell proliferation data on doses where tumor
information is not available are of limited use.
Likewise, cell proliferation data obtained after acute
dosing may be misleading for determining correlations
with tumorigenicity. Continuous labeling with
[3H]thymidine or 2-bromodeoxyuridine via osmotic
pumps to identify S-phase cells is recommended for
most studies as this technique is more sensitive than
pulse administration oflabel. Microscopic identification
of the site of cytotoxicity and the cell type of preneo-
plastic and neoplastic lesions is important for deter-
mining the target cell population. Perfusion, rather
than immersion fixation of the kidney and thin (2-3
gm) sections may be needed to adequately characterize
cytotoxicity and preneoplastic lesions. In addition, pre-
neoplastic and neoplastic lesions should be examined in
Table 2. Developing a data set on cytotoxicity,
cell proliferation, and renal cell tumors.
Use bioassay doses at multiple time points to evaluate cytotoxicity
and renal cell proliferation
Determine the site ofcytotoxicity and cell type ofpreneoplastic
and neoplastic lesions by light microscopy
Evaluate cell proliferation using a technique to identify S-phase
cells
Evaluate differential cytotoxicity and cell replication in lesion and
nonlesion tissue, including separation ofchronic progressive
nephropathy from lesion and nonlesion tissue
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as many sections per kidney as possible (at least 4 sec-
tions/kidney). Established classification schemes for
preneoplastic and neoplastic lesions should be used to
maintain consistency of terminology. A generalized
and more widely used classification, which incorporate
early lesions, has recently been proposed and may
improve the current database on renal lesions (46). It
is advisable to separate epithelial from interstitial
cells, as well as proximal from distal tubular epithelial
cells in quantitation. Identification of P1, P2 and P3
proximal tubule cells may be critical in certain cases,
such as ac2uG-inducing agents. Tubules affected by
CPN should be counted as a separate entity because
their relevance to tumorigenesis is unknown.
Additional Information Needed for
Modeling Renal Cancer
Simply measuring cell proliferation is inadequate for
judging whether a chemical will ultimately increase
the risk ofcancer. The ultimate goal for such investiga-
tions in renal cancer should be two-stage growth mod-
eling, similar to approaches developed for the liver and
urinary bladder (47). Because the most relevant prolif-
eration is that which occurs in the stem cell population,
future cell proliferation studies in the kidney should be
directed toward collecting these data within preneo-
plastic lesions, using recently developed biochemical
markers of these lesions (48,49). Second, the total
number of stem cell divisions, not only proliferation
rate, must be ascertained. Thus, we need to include
data on the number ofnormal cells and stem cells with-
in the kidney. Third, we should include cell death rates,
which means we need to begin to identify and count
apoptotic renal cells.
Mechanisms of Renal Cell
Proliferation
Studies of oncogenes, tumor-suppressor genes, and
growth factors are essential for our understanding of
the relationships between cell proliferation and renal
cancer. The Eker rat, a model for hereditary renal cell
carcinoma, has altered expression of transforming
growth factor-a in early tumor development, but no
expression is observed in highly replicating CPN foci
(49). Cell proliferation studies in carrier and noncarrier
rats have demonstrated increased cell proliferation
rates in atypical tubules, atypical hyperplasias, and
renal cell tumors (50). Labeling indexes in normal and
CPN foci did not differ between carrier and noncarrier
rats. This animal model may prove useful for investiga-
tions into the genetic basis for spontaneous and car-
cinogen-induced renal cell cancer, including relation-
ships between growth-factor expression and cell
proliferation in lesion and nonlesion tissue.
Investigating the nephrogenic repair response may
be valuable for clarifying our understanding of renal
cancer. Nephrotoxic and nephrocarcinogenic halo-
alkenes, which form toxic and mutagenic intermediates
by the cysteine conjugate P-lyase pathway, cause
necrosis of P3 proximal tubule epithelial cells. This
event leads to a dramatic site-specific increase in cell
proliferation, followed by a decrease in differentiation
(dedifferentiation), and an increase in markers more
characteristic of embryonic kidney (51). Furthermore,
proliferation but not dedifferentiation occurs in
undamaged P2 proximal tubule cells. Proliferation and
dedifferentiation of P3 proximal tubule cells may be
important in transformation to a malignant phenotype
(52).
Investigations on kinematics, or the movement of
proliferating cells, within the nephron have identified
two kinetic compartments: a progenitor compartment
composed of proximal and distal convoluted epithelia
and a part of thick, straight tubules, and a quiescent
compartment composed of the remaining nephron
within the papilla (53). Cells in the cortical regions of
the nephron stream toward the papilla at a rate of 1.1
locations/day and are eliminated. The importance of
kinematics in nephrotoxicity and renal carcinogenesis
is unknown, but may be important for understanding
the repair response ofthe nephron.
Conclusions
Relationships between sustained renal cell prolifera-
tion and carcinogenic potential have been established
for several chemicals, but general conclusions must
await data from correlative studies with other chemi-
cals, including studies with noncarcinogens as well as
carcinogens. Cell proliferation rates as well as total cell
numbers should be quantitated in lesion and nonlesion
tissue. Counting and classifying preneoplastic and neo-
plastic lesions must be thorough and standardized.
Underlying mechanisms ofrenal cell proliferation must
be understood before cause and effect relationships are
drawn.
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